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Background: The Centers for Disease Control and Prevention’s (CDC) National Healthcare Safety Network (NHSN)
report published in 2009 shows that there were about 16,000 cases of surgical site infection (SSI) following ~ 850,000
operative procedures making SSI one of the most predominant infection amongst nosocomial infections. Preoperative
skin preparation is a standard procedure utilized to prevent SSIs thereby improving patient outcomes and controlling
associated healthcare costs. Multiple techniques/ products have been used for pre-operative skin preparation, like 2 step
scrubbing and painting, 2 step scrubbing and drying, and 1 step painting with a drying time. However, currently used
products require strict, time consuming and labor-intensive protocols that involve repeated mechanical scrubbing. It can
be speculated that a product requiring a more facile protocol will increase compliance, thus promoting a
reduction in SSIs. Hence, the antimicrobial efficacy of a spray-on foaming formulation containing Betadine
(povidone-iodine aerosol foam) that can be administered with minimum effort is compared to that of an
existing formulation/technique (Wet Skin Scrub).
Methods: In vitro antimicrobial activities of (a) 5% Betadine delivered in aerosolized foam, (b) Wet Skin Scrub
Prep Tray and (c) liquid Betadine are tested against three clinically representative microorganisms (S. aureus, S.
epidermidis and P. aeruginosa,) on two surfaces (agar-gel on petri-dish and porcine skin). The log reduction/
growth of the bacteria in each case is noted and ANOVA statistical analysis is used to establish the effectiveness
of the antimicrobial agents, and compare their relative efficacies.
Results: With agar gel as the substrate, no growth of bacteria is observed for all the three formulations. With
porcine skin as the substrate, the spray-on foam’s performance was not statistically different from that of the
Wet Skin Scrub Prep technique for the microorganisms tested.
Conclusions: The povidone-iodine aerosolized foam could potentially serve as a non-labor intensive antimicrobial agent
for surgical site preparation.
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Surgical site infection (SSI) is one of the major concerns
associated with surgery [1,2]. SSIs can lead to severe
complications, and also to patient mortality in extreme
cases [3]. A 2009 estimate of the annual direct medical
costs of Hospital Acquired Infections (HAI) by the
Centers for Disease Control and Prevention (CDC) esti-
mated the number of SSIs in USA to be >290,000 per
year, with an estimated cost of resulting inpatient ser-
vices of up to $ 10 Billion [4]. A reduction in the inci-
dences of SSI would thus greatly improve patient
wellbeing with a significant reduction in healthcare ex-
penses [5,6].
Colonizing microorganisms often cause SSI. Microor-
ganisms present on the skin and the operation room can
readily enter a patient’s body through the site of an inci-
sion [7]. Transient bacteria present on the skin can and
do cause SSIs, and reducing their number is of vital im-
portance. This is achieved using a combination of pro-
cesses: sterilization of the operating room, cleaning,
showering and de-hairing of the surgical site, and scrub-
bing the surgical site with antimicrobial agents [7,8].
Commonly used antimicrobial agents are alcohol, iod-
ine, chlorohexidine and povidone-iodine solution (PVP-
I) among others [3]. They can be administered in the
form of liquids and solutions [1]. The choice of anti-
microbial agent and the technique of preoperative skin
preparation to be used depends on various factors like
surgeon’s familiarity with the technique, cost, efficacy of
the agent used, ease of use, surgical site and possible
bacteria present at the site [9]. There are several tech-
niques like 1-step paint and dry method (taking about
3 minutes) or only scrub and dry techniques (taking
greater than 5 minutes) or scrub-paint technique (taking
about 5 minutes) [10-13]. We selected the wet skin
scrub prep technique as it is a commonly used technique
in the operating room, and the technique of choice for a
number of clinicians at our institution. Drawbacks of the
current protocols of surgical site preparation techniques
are; they are laborious, time consuming, expensive and
often require the user to follow certain strict protocols
[3,8,14]. It is speculated that a product sprayed directly
at and/or near the surgical site would be able to over-
come these disadvantages, resulting in reduction in time,
effort and personnel needed for surgical site preparation,
and hence cost incurred.
While there are multiple products available for surgical
site preparation (with varying, but broadly comparable
efficacies) a common preoperative surgical site preparation
technique involves a 5 minute scrub with povidone-iodine
detergent [15]. If the 5-minute scrub is replaced with a
spray-on protocol taking 2 minutes, it could result in saving
3 minutes during every surgical procedure. Given average
operating room charges of $62/minute, this three-minutereduction in surgical site preparation will result in savings
of $186/case if the cost of the spray on product is similar to
the existing technique [16]. This increased efficacy would
result in saving $0.93 million a year and also generate
15,000 minutes of extra procedure time for hospitals that
annually perform about 5000 procedures. The time saved
can be rightfully utilized for additional procedures. In
addition, SSIs have been estimated to increase hospital ex-
penses per admission by $ 20,842 [17]. So reduction of both
extra procedure time and incidence of SSI, can lead to re-
duction in financial burden of the patient.
It is estimated that a large percentage of surgical site
infections (up to 60%) can be prevented following proper
surgical site preparation techniques [18]. Therefore, any
preoperative skin cleaning technique whose efficacy is at
least equal to that of the existing methods, but which is




The bactericidal efficacy of our spray-on formulation
(povidone-iodine aerosol foam), is compared to that of
the traditional sponge-based application method using
the methodology schematically depicted in Figure 1.
Details regarding individual steps in the protocol are de-
scribed below. Standard 0.5 McFarland bacterial suspen-
sions are spread on two different substrates: sterile
nutrient agar and sterilized porcine skin. The substrates
are incubated for an hour to allow sufficient time for the
bacteria to adhere to the substrates. Post incubation, the
surfaces are exposed to the various preoperative skin
preparation techniques: povidone-iodine aerosol foam,
wet skin scrub prep tray, flood-coverage with liquid
Betadine (positive control) and flood-coverage with
Phosphate buffer saline (PBS) or no-treatment (nega-
tive control). Post-exposure, the substrates are again
incubated for 24 hours. After 24 hours, the number of
surviving bacteria is estimated using colony counts, to
estimate the bactericidal efficacy of the various tech-
niques. 48 hours incubation of the plates is also done
to validate if the bacteria are killed during the process
or are merely injured and could grow if proper nutri-
ents are provided to it [19].
Bacterial cell culture
The micro-organisms used in the study are gram-
positive bacteria Staphylococcus aureus ATCC 29213
and Staphylococcus epidermidis ATCC 12228 and gram-
negative bacteria Pseudomonas aeruginosa ATCC 27853.
The bacterial strains chosen for the study contribute to
about 42% of SSI [7]. The strains are sub-cultured in
Tryptic Soy Broth (TSB) and incubated for 20–24 hours
at 37°C to obtain log-culture. Following which standard
Figure 1 Schematic of the method of testing the bactericidal efficacy. This schematic details the methodology of testing the bactericidal
efficacy using Povidone-iodine aerosol foam, sponge based applicator and flood-coverage with liquid Betadine.
Kargupta et al. Annals of Clinical Microbiology and Antimicrobials  (2015) 14:20 Page 3 of 80.5 McFarland bacterial suspension is prepared in TSB
for use in the study using standard protocols [20].
Selection of substrates
The antimicrobial efficacy of the agents used for pre-
operative skin preparation is tested in vitro using both
agar plates as well as porcine skin. Tryptic Soy Agar
(TSA) plates are used for culturing the bacteria.
Porcine skin is chosen for its close resemblance to hu-
man skin, and has previously also been used for studying
the effect of chemicals on human skin [21,22]. Porcine
skin purchased from local grocery shops is cleaned, de-
haired and cut into one square inch pieces and sterilized,
prior to use. The sterilization protocol, described in de-
tail elsewhere [23] involved treating the skin pieces with
an aqueous solution of 1 M sodium chloride and 0.1%
(v/v) per-acetic acid with continuous stirring of the solu-
tion at 225 rpm for 30mins. It is followed by two times
rinsing in PBS for a period of 24 hours each time by
continuous stirring at 225 rpm [23,24].
Selection of antimicrobial agents for testing
Liquid 5% Betadine is used for flood-coverage of the
substrates. Preoperative wet skin scrub prep kit contain-
ing sponge applicators are used for the study with the
applicators wetted with 5% Betadine prior to scrubbing.
Aerosolized foam of povidone-iodine, 5% Betadine is
used. The product is designed to be sprayed on thesurgical site from a distance of 4–8 inches, resulting in
the site being covered with foam. The propellant gases
present in the aerosol foam canister mix with anti-
microbial agents like povidone and iodine to produce a
layer of foam. It requires less manual labor unlike scrub-
bing or painting. After predetermined contact time, the
foam can be removed from the site with a sterile cloth
thus making the site ready to be operated on.
In addition, to prove that there is no mechanical wash-
ing away of the bacteria on being flooded with 5% Beta-
dine, the experiment was repeated with 1X PBS instead
of 5% Betadine.
Evaluation of bactericidal activity
For each bacterial culture, both agar plates and porcine
skin are used. 5 agar plates are used for each case:
control, flood-coverage by 5% Betadine, sponge-based
applicator and povidone-iodine aerosolized foam (our
product). Similarly, for porcine skin, a group of 5 one
inch square skin pieces are used for each case, control,
flood-coverage with 5% Betadine, sponge based applica-
tor and our product.
Each bacterial culture is diluted to ~1*104 CFU/ml
and 100 μl is of the diluted bacteria is used for inocula-
tion. It is thus expected that there will be ~103 CFU on
agar plates and porcine skin prior to disinfection. Post-
inoculation, the agar plates and the porcine skin are
allowed to incubate at room temperature for 1 hour.
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plates are allowed to incubate at 37°C for 24 hours. Imprint
of the control samples of the porcine skin are taken on agar
plates with the plates being incubated at 37°C for 24 hours.
It may be noted that samples were incubated for 48 hours
in the hope of detecting bacteria that were only injured, but
not killed by the disinfecting techniques [19].
The steps involved in treating the agar plates and the
porcine skin with flood-coverage of Betadine, aerosolized
foam and sponge based applicator are depicted in
Figures 2 and 3, respectively.
For agar plates and skin pieces serving as substrate for
5% Betadine about 5-10 ml of liquid 5% Betadine, is poured
on the surface. This ensures flooding and complete cover-
age of the entire surface of the agar plates/porcine skin with
5% Betadine. After 2 minutes of contact, the agar plates are
flipped upside down to remove excess solution. In case of
porcine skin, the skin is taken out and shaken well to re-
move excess solution and imprinted on agar plates.
For groups of agar plates and skin pieces being used for
our product, aerosolized foam is sprayed on the surface.
After two minutes of contact time the aerosolized foam is
removed from the surface and in case of porcine skin the
imprints of the skin are taken on agar plates. Similarly for
the agar plates and porcine skin pieces used for sponge
based applicator, the sponge post wetting with liquid 5%
Betadine is gently rubbed on the inoculated surface inFigure 2 Steps involved in evaluating bactericidal activity on nutrient ag
Betadine, aerosolized foam and sponge based applicator and evaluating its bacregular motion. The porcine skin is held firmly with a
sterilized forceps to enable researchers to scrub the surface
thoroughly, in a manner similar to the real world situation.
Damaged plates resulting from scrubbing were discarded.
Post surface rubbing with the wet sponge for two minutes,
a dry sponge is used to remove the excess liquid. In
case of the porcine skin, they are taken out and
imprinted on agar plate.
Statistical analysis
Statistical analysis was performed in Microsoft Excel
using analysis of variance (ANOVA) single factor to es-
tablish the efficacy of the antimicrobial agents used. A
measure of significance of differences is the p-value. The
p-value thus provides a more intuitive feel of the degree
of difference between the two quantities being compared.
For our case, the null hypothesis is that the number of sur-
viving bacteria (colonies) remaining is equal for the two
processes that we compare, namely, aerosolized foam and
sponge based applicator.
Results
Figure 4 shows the number of live bacteria remaining on
the surface of the agar plate after addition of 100 μl
suspension with 104 CFU of bacteria/ml on a TSA petri-
dish, and subsequent treatment with the disinfection proto-
cols of interest. For the control (no disinfectant applied),ar plates. Steps involved in treating the agar plates with flood-coverage of
tericidal activity.
Figure 3 Steps involved in evaluating bactericidal activity on porcine skin. Steps involved in treating the porcine skin with flood-coverage
of Betadine, aerosolized foam and sponge based applicator and evaluating its bactericidal activity.
Figure 4 Viable bacterial count for different bacteria tested on agar plates. Number of live bacteria (CFU/100 μL) observed on agar
plate after 24 hours and 48 hours for negative control (no treatment done), application of aerosolized foam, application of sponge based
applicator and positive control (application of 5% Betadine) for S. aureus (top left) [n = 4], P. aeruginosa (top right) [n = 5] and S. epidermidis
(bottom left) [n = 5].
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Figure 5 Viable bacterial count for different bacteria tested on porcine skin. Number of live bacteria (CFU/100 μL) observed on porcine skin after
24 hours and 48 hours for negative control (no treatment done), application of aerosolized foam, application of sponge based applicator and positive
control (application of 5% Betadine) for S. aureus (top left) [n = 4], P. aeruginosa (top right) [n = 5] and S. epidermidis ((bottom left) [n = 5].
Table 1 p-values calculated using null hypothesis for all
applications
Bacterial species Observation time period Porcine skin
S. aureus 24 hrs -
48 hrs 0.1682
P. aeruginosa 24 hrs 0.4876
48 hrs 0.3486
S. epidermidis 24 hrs 0.4929
48 hrs 0.2819
List of p-values, as calculated for the null hypothesis that the two disinfection
protocols (aerosolized foam and sponge based applicator) are equally
effective. (n = 4 for S. aureus; n = 5 for S. epidermidis and P. aeruginosa).
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48 hours. More importantly, all the disinfection protocols,
like povidone-iodine aerosol foam, sponge based applicator,
and flood-coverage with liquid 5% Betadine (positive con-
trol) are equally effective for all three bacterial species
tested (S. aureus, P. aeruginosa and S. epidermidis). All bac-
teria are eliminated (no colonies are seen after 24 or 48 hrs
of incubation, post-treatment).
Figure 5 show the results of the tests conducted on por-
cine skin subjected to the same preoperative skin prepar-
ation (disinfection) techniques tested against the same set
of bacteria. In this case, different disinfection protocols have
different outcomes. It is noteworthy that (as expected for a
positive control), the flood coverage with liquid Betadine is
able to completely eliminate all bacteria present in this case
as well. For the applicator sponge (currently used method
for pre-operative skin disinfection), none of the bacteria
tested were completely eliminated, although in 2 of the 3
cases (S. aureus and P. aeruginosa) all were at least injured
(no colonies seen at 24 hrs). With the foaming betadine
suspension (new product being investigated), the results ob-
tained did not show statistically significant difference when
compared to the sponge-applicator for all the bacteria
tested. S. aureus was completely eliminated, and the num-
ber of colonies observed for the two other bacteria was
lesser than the corresponding number for the sponge-
applicator at both 24 and 48 hrs. The p-values obtained
when comparing corresponding readings (same bacteria,
same duration of incubation) are shown in Table 1.When the experiment was repeated by flood coverage
of the plates with 1X PBS it was observed that the plates
showed bacterial growth similar to that of the control
samples for both the substrates. This clearly indicated
that there was no mechanical washing of the bacteria
when flooded with Betadine but antimicrobial effects
arose due to the chemical activity of 5% Betadine.Discussion
For agar plates as a substrate, the aerosolized foam, like
the other existing methods of application, has a very
strong bactericidal effect, as observed from the lack of
colonies even after 48 hours for all the disinfection
methods examined. Given that these plates provide a
smooth surface for the antimicrobial agents to come into
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ideal case.
Porcine skin can be considered as a more realistic
model for studying human skin in-vitro. Here, the bac-
tericidal effect of the agents tested is mitigated by pores,
folds and other structures in the skin that prevent the
antimicrobial agents from sustained contact with the
bacteria. Though all agents show approximately 2-log re-
ductions in bacterial number, the tested foam did not
have any statistically significant difference in efficacy
when compared with the other agent/method tested as
seen from the statistical analysis. It may be noted that
none of the current surgical site preparation practices
can completely sterilize skin.
Further, this is a preliminary study that merely looks
at the efficacy of the foam against three bacterial species
in-vitro, and it only suggests that the foam can be used
for surgical site preparation. Additional studies on live
animals and/or humans in a “real-world” setting may be
needed before one can accurately establish how effective
it is compared to other formulations/ methods available
in the market, and whether there are any conditions
under which it may not be as effective.Conclusion
This study shows that using a new delivery system
(aerosolized foam) for an established antiseptic (beta-
dine) achieved bactericidal results comparable to a trad-
itional system that is currently used when tested in-vitro
on both agar plates and porcine skin.
Given the limitations of this preliminary study, further
studies venturing into clinical trials will be needed to obtain
substantial evidence for SSI prevention using this product.
Such studies will also explore how the aerosolized foam
compares with many other kinds of surgical skin prepar-
ation products/techniques and whether the anticipated ad-
vantages of using the aerosolized foam (lower “error” rate
due to its ease of use, and saving healthcare costs by virtue
of requiring less time compared to the standard method)
can be realized in a “real world” clinical setting.
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